Abstract
The purpose of this document is to characterize the market for diagnostic products for the detection of HIV, with a focus on HIV simple/rapid, enzyme immunoassay (EIA), and supplemental tests. This document is intended to provide:
• An overview of technologies that were purchased during the time period analyzed in the report;
• Analysis of available procurement data and information gaps; and
• Discussion of issues related to market dynamics for HIV simple/rapid, EIA, and supplemental tests
This document was prepared based on market data available in the timeframe required, and is intended as a basis for discussion. Due to critical gaps in the available data, it is recommended that this market analysis be updated as and when additional or improved data are available.
